The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oncologists’ perspectives on individualizing dose selection for patients with metastatic cancer.
 
Rachel Jimenez
Employment - Biogen (I)
Stock and Other Ownership Interests - Biogen (I)
Research Funding - Focal Therapeutics
 
Caroline Schenkel
No Relationships to Disclose
 
Laura Levit
No Relationships to Disclose
 
Bonnie Hu
No Relationships to Disclose
 
R. Donald Harvey
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; GlaxoSmithKline
Research Funding - Abbisko (Inst); Abbvie (Inst); Actuate Therapeutics (Inst); Alkermes (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Calithera Biosciences (Inst); Fujifilm (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); InhibRx (Inst); Merck (Inst); Mersana (Inst); Meryx Pharmaceuticals (Inst); Nektar (Inst); Pfizer (Inst); Puma Biotechnology (Inst); RAPT Therapeutics (Inst); Rgenix (Inst); Seagen (Inst); Sutro Biopharma (Inst); Takeda (Inst); Xencor (Inst)
 
Vicki A. Morrison
Consulting or Advisory Role - Merck
Speakers' Bureau - Bristol-Myers Squibb/Celgene
Patents, Royalties, Other Intellectual Property - Up-to-Date author (Pathogenesis of infection in CLL pts, prevention of infection in CLL pts)
 
Teri Pollastro
Employment - Sengine Precision Oncology (I)
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
David Michael Waterhouse
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AZTherapies; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Fresenius Kabi; Janssen Oncology; Jazz Pharmaceuticals; Lilly; McGivney Global Advisors; Merck; Mirati Therapeutics; Pfizer; Sanofi; Sanofi/Regeneron; Seagen
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Janssen Oncology; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Colin D. Weekes
Honoraria - Bayer; Celgene; Lilly
Consulting or Advisory Role - Celgene; Ipsen; Merrimack
Research Funding - Abbvie; Actuate Therapeutics; AstraZeneca; Bayer; Celgene; Dicephera Pharmaceuticals, Inc.; Genentech/Roche; Gilead Sciences; Halozyme; Ipsen; Lilly; Millennium; Novartis
Travel, Accommodations, Expenses - Bayer; Celgene; Lilly
 
Grant Richard Williams
Honoraria - Cardinal Health; Carevive Systems
 
Suanna Steeby Bruinooge
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
No Relationships to Disclose
 
Jeffrey M. Peppercorn
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Abbott Laboratories; athenex
Research Funding - Outcomes4Me